retatrutide weight loss retatrutide clinical trial A New Obesity Drug Delivered Surgery-Level in Trials Phase III retatrutide study demonstrates

Below are some of the most commonly used GLP-1 medications: Dulaglutide (Trulicity) Exenatide (Bydureon BCise) Liraglutide (Saxenda, Victoza) Semaglutide (Ozempic, Rybelsus, Wegovy) Tirzepatide (Mounjaro, Zepbound) These medications differ in their dosing schedules, mechanisms of administration, and specific indications, but all work the same to improve blood sugar levels and support improved long-term health outcomes

The study was sponsored by Eli Lilly, the maker of Mounjaro and Zepbound

10.1093/brain/awac012 Brain 143 RoyN.ClerenC.SinghS.YangL.BealM.GoldmanS

We do things the way we'd want our own lawyer to handle our case if we were the client